Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 340

Results For "bio"

3855 News Found

India’s first mRNA vaccine should be ready soon
News | February 11, 2022

India’s first mRNA vaccine should be ready soon

It is being developed by Pune-based Gennova Biopharmaceuticals


X-Chem and Excelra's GOSTAR team up to discover drugs for challenging targets
Digitisation | February 10, 2022

X-Chem and Excelra's GOSTAR team up to discover drugs for challenging targets

GOSTAR's proprietary data set underwent rigorous analysis and large-scale ML model building to predict drug solubility in a recent joint study. X-Chem's RosalindAI delivered superior and actionable results than other similar analyses using well-known publically available datasets


Health Canada gives breakthrough approval for Dolphin Vagal Stim device to treat Covid-19
Drug Approval | February 10, 2022

Health Canada gives breakthrough approval for Dolphin Vagal Stim device to treat Covid-19

The vagus nerve is the longest nerve in the body that travels down from the brain to innervate and control breathing, stress levels and inflammation


Scientists breaking barriers to treating heart failure
Medical Device | February 09, 2022

Scientists breaking barriers to treating heart failure

Cysoni is a bionic device that paces the heart with real-time respiratory modulation. The innovation stems from the idea that heart rate increases and decreases with each breath in normal physiology, termed ‘respiratory sinus arrhythmia’ (RSA)


Strand Therapeutics appoints Dr. Prashant Nambiar as Senior VP
People | February 09, 2022

Strand Therapeutics appoints Dr. Prashant Nambiar as Senior VP

Senior R&D leader from Pfizer and bluebird bio to support Strand’s platform of programmable mRNA-based therapeutics


Glenmark launches nasal spray to treat Covid-19
News | February 09, 2022

Glenmark launches nasal spray to treat Covid-19

Glenmark received manufacturing and marketing approval from DCGI for Nitric Oxide Nasal Spray (NONS) as part of accelerated approval process


EdiGene and Neukio collaborate to develop next-generation immune cell therapies
Biotech | February 09, 2022

EdiGene and Neukio collaborate to develop next-generation immune cell therapies

The collaboration will leverage EdiGene’s expertise in high-throughput genome editing screening and Neukio’s strength in the development and manufacturing of induced pluripotent stem cell (iPSC) and natural killer cell (NK Cell)


Everest Medicines' trodelvy approved in Singapore for second-line metastatic triple-negative breast cancer
Drug Approval | February 08, 2022

Everest Medicines' trodelvy approved in Singapore for second-line metastatic triple-negative breast cancer

Singapore Health Sciences Authority (HSA) approval marks the first in a series of expected approvals of trodelvy in Asia


Wockhardt gets CDSCO nod to export 100 million doses of Sputnik vaccines
News | February 08, 2022

Wockhardt gets CDSCO nod to export 100 million doses of Sputnik vaccines

Wockhardt has entered into an agreement with Russian Direct Investment Fund and Enso Healthcare to manufacture and supply Sputnik V and Sputnik Light vaccines against Covid-19


Merck KGaA restructures life science business to support long-term growth
News | February 08, 2022

Merck KGaA restructures life science business to support long-term growth

Newly formed Life Science Services business unit to offer fully integrated CDMO and Contract Testing Services